Can Glycine Cause Headaches? What the Evidence Says

No well-designed clinical trial has identified headaches as a consistent side effect of glycine supplementation, even at high doses. That does not mean the connection is imaginary, though. Glycine sits at a neurochemical crossroads, acting as both an excitatory co-activator on one type of brain receptor and an inhibitory signal on another. Those dual roles create plausible biological pathways linking glycine to headache in theory, and a small number of supplement users do report head pain. Understanding why requires looking at what glycine actually does once it reaches the brain.

Glycine’s Dual Identity in the Nervous System

Glycine is the simplest amino acid, but its behavior in the brain is anything but simple. It plays two distinct, almost opposite roles depending on which receptor it binds to. On one hand, glycine functions as one of the major inhibitory neurotransmitters in the spinal cord and brainstem, helping to calm nerve signaling and regulate movement. Glycinergic synapses there work alongside GABA, the brain’s main inhibitory chemical, to keep neural circuits from firing too aggressively.¹

On the other hand, glycine is a required co-activator of NMDA receptors, a class of receptors that drive excitatory signaling throughout the brain. NMDA receptors are unusual because they need two chemicals present simultaneously to open: glutamate, the brain’s primary excitatory neurotransmitter, and glycine as a co-agonist. Without glycine occupying its binding site, glutamate alone cannot fully activate NMDA channels.² This means glycine modulates how strongly and how long NMDA receptors respond to glutamate signals, influencing the amplitude and timing of excitatory currents.³

This dual identity is the reason the glycine-headache question resists a simple yes or no. Depending on context, dose, and where in the nervous system glycine is acting, it could theoretically promote or dampen the processes that lead to headache. The excitatory NMDA pathway is the one that raises the most concern.

NMDA Receptors, Cortical Spreading Depression, and Migraine

The strongest theoretical link between glycine and headache runs through a phenomenon called cortical spreading depression, or SD. This is a slow wave of electrical silence that sweeps across the brain’s surface, preceded by a burst of intense depolarization. SD is widely believed to underlie the aura phase of migraine and may also contribute to headache pain itself by activating pain-sensing nerves in the meninges. Researchers have established that NMDA receptors play a role in triggering and propagating these waves.

Here is where glycine enters the picture. Because glycine is required for NMDA receptor activation, anything that influences glycine availability at the receptor can influence SD. Research on a compound called L-701,324, which blocks the glycine binding site on NMDA receptors, found that it inhibited both the initiation and the spread of potassium-induced SD in rat brains. The researchers specifically noted that this blocking action could be beneficial against migraine.⁴

A separate line of research tested GLYX-13, a partial agonist at the glycine site, meaning it activates the site but less powerfully than glycine itself does. GLYX-13 sometimes completely prevented SD from being triggered and consistently slowed its propagation in brain tissue slices. The researchers proposed that modulating NMDA receptor activity through the glycine binding site could be a treatment strategy for migraine and related conditions.⁵

The logic flows in a clear direction: if blocking or partially activating the glycine site suppresses the brain wave phenomenon behind migraine, then flooding that site with more glycine could theoretically do the opposite. That is the concern that gives the glycine-headache hypothesis its biological plausibility. But “theoretically could” is different from “actually does,” and the gap between pharmacological experiments in rodent brain tissue and a human swallowing a glycine capsule is enormous.

Glycine and Blood Vessel Dilation in the Brain

A second mechanism that could connect glycine to headache involves blood vessels. When researchers applied glycine solution directly to the tiny arteries on the surface of the brain (called pial microvessels), they observed dramatic dilation. The arterioles expanded by 150 to 250 percent of their original diameter within one to three minutes, and the effect lasted about 10 to 15 minutes before the vessels returned to normal size. Interestingly, the veins in the same area did not respond, and the pH of the glycine solution made no difference to the result.⁶

Vasodilation of arteries in and around the brain has long been discussed in headache research, particularly in relation to migraine. The older “vascular theory” of migraine, which proposed that headache pain was caused primarily by dilated blood vessels pressing on pain-sensing nerve fibers, has largely been replaced by more complex neurological models. But vascular changes still play a role in the full picture of migraine pain. A substance that reliably dilates brain arteries is at least worth flagging in any conversation about headache risk.

Glycine also causes vasodilation in the periphery. Research on glycine’s sleep-promoting effects found that oral glycine increased blood flow to the skin surface, particularly on the soles of the feet, in a dose-dependent manner. This heat-loss mechanism is part of how glycine lowers core body temperature and promotes sleep onset.⁷ Peripheral vasodilation is generally not associated with headache, but it illustrates that oral glycine does affect blood vessels systemically, not just in the laboratory when applied directly to brain tissue.

Glycine’s Protective Side in Pain Signaling

The theoretical case against glycine does not go unchallenged by glycine’s own biology. In the trigeminal system, the network of nerves responsible for sensation in the face, head, and the meninges surrounding the brain, glycine receptors appear to play an inhibitory, pain-dampening role. Researchers have identified a specific glycine receptor subtype, called GlyRα3, in rat trigeminal neurons and in the nerve terminals they send into the brainstem. The findings suggest that glycine provides presynaptic inhibition in this system, essentially turning down the volume on pain signals before they reach higher brain centers.⁸

Additional research has explored glycine receptor activity in the spinal trigeminal nucleus, a brainstem region that processes pain and sensory information from the head and face. This work found that glycine receptor-mediated inhibitory signaling in that region can be modulated by cholinergic (acetylcholine-related) pathways, adding further complexity to how glycine influences head pain processing.⁹

So glycine is simultaneously a theoretical headache promoter (through NMDA receptor enhancement and cerebral vasodilation) and a theoretical headache protector (through inhibitory glycine receptors in the trigeminal pain pathway). Which effect dominates in a real person taking a real supplement is something no clinical study has directly tested. The evidence on both sides comes from animal models and pharmacological experiments, not from tracking headache outcomes in glycine users.

What Human Studies Actually Report About Side Effects

The clinical trial literature on glycine supplementation is thin, but what exists is worth looking at. Some of the highest doses ever given to humans in controlled settings occurred in schizophrenia research, where glycine was tested as an add-on therapy at doses reaching 60 grams per day, far beyond the 3 to 5 grams typical in sleep or wellness supplements. In one such trial, the most notable side effect was gastrointestinal: one participant was withdrawn at six weeks because of upper GI discomfort with nausea and vomiting, which resolved after stopping glycine.¹⁰ Headache was not flagged as a significant adverse event in that trial.

Collagen supplements, which deliver a substantial glycine load because glycine makes up roughly a third of collagen’s amino acid content, provide another window into safety. A meta-analysis of randomized controlled trials testing collagen peptides for knee osteoarthritis found no significant difference in the overall risk of adverse events between collagen and placebo groups.¹¹ That does not rule out headache as an occasional individual reaction, but it does suggest that glycine-rich supplements at commonly used doses are not producing headaches at rates that stand out in clinical trials.

The absence of evidence is not evidence of absence, as the saying goes, but it does set a useful boundary. If glycine caused headaches frequently or severely, something would likely have surfaced in decades of clinical use, especially at the very high doses used in psychiatric research. The fact that GI problems are the most commonly reported complaint, rather than headache, shifts the weight of evidence away from glycine being a reliable headache trigger for most people.

Why Some People Might Still Get Headaches

Anecdotal reports of headache after taking glycine supplements do exist in online forums and product reviews. Dismissing these entirely would be a mistake, but understanding the many possible explanations is important before blaming glycine itself.

Individual sensitivity: People prone to migraine often have a lower threshold for cortical spreading depression. In someone whose NMDA receptors are already near their activation threshold, even a modest increase in glycine availability could theoretically nudge things along. This remains speculative, but it aligns with the basic neuroscience.
Dose matters: A person taking 3 grams at bedtime for sleep is in a very different pharmacological situation from someone consuming 30 or 60 grams for another purpose. Dose-response relationships in neuroscience are rarely linear, and the brain has compensatory mechanisms, but extremely high doses are more likely to push past normal regulatory boundaries.
Supplement quality: Glycine is cheap and widely manufactured, but not all products are equal. Contaminants, fillers, or other amino acids present in lower-quality products could be responsible for symptoms incorrectly attributed to glycine.
Timing and context: Taking glycine on an empty stomach, combining it with other supplements that affect NMDA signaling (like magnesium or D-serine), or consuming it alongside caffeine withdrawal or dehydration could create conditions where a headache emerges from the combination rather than from glycine alone.

None of these explanations have been tested in controlled studies, which is part of the frustration. The research community has simply not prioritized the question of whether glycine causes headaches, partly because glycine is considered so safe and partly because supplement side effects in general receive less research funding than drug side effects.

Getting Glycine From the Blood Into the Brain

One reason to be cautious about extrapolating from lab experiments to human experience is the blood-brain barrier. Glycine does not move freely from the bloodstream into the central nervous system. Transport across these barriers involves specific carrier systems, including glycine transporter 1 (GlyT1) and system A transporters, which have been characterized in related barrier tissues. Research on the blood-retinal barrier, which shares structural and functional similarities with the blood-brain barrier, found that glycine transport is sodium- and chloride-dependent and follows saturable kinetics, meaning the transport system has a ceiling.¹²

The practical implication is that swallowing even a large dose of glycine does not produce a proportional flood of glycine in the brain. The transport system acts as a gatekeeper. Brain glycine levels are regulated and buffered, which is one reason why oral glycine at normal supplement doses is generally well tolerated. The dramatic vasodilation observed when glycine solution was applied directly to exposed brain arteries involved concentrations and exposure patterns that oral supplementation probably does not replicate.

Glycine Encephalopathy and Extreme Cases

There is one medical condition that vividly illustrates what happens when glycine levels in the brain become dangerously elevated. Nonketotic hyperglycinemia, also called glycine encephalopathy, is a rare inherited metabolic disorder in which the enzyme system that breaks down glycine is defective. Glycine accumulates to toxic concentrations in the brain and cerebrospinal fluid. In its severe form, the condition typically presents in newborns with seizures, breathing difficulties, and profound developmental impairment. Attenuated forms can appear later in life with milder neurological symptoms.¹³

This condition is not relevant to supplement users in any direct way. The glycine levels involved are orders of magnitude beyond what oral supplementation can achieve, and the underlying problem is genetic, not dietary. But glycine encephalopathy does confirm that glycine, at extreme concentrations, is neurotoxic and can overstimulate NMDA receptors to the point of causing seizures and brain damage. It serves as a biological proof of concept that too much glycine in the brain is harmful, even if normal supplementation does not approach those levels.

Sleep Benefits and the Headache Paradox

One of the best-studied uses of supplemental glycine is for sleep improvement. Research has shown that oral glycine promotes non-REM sleep and shortens the time it takes to fall asleep, with a simultaneous drop in core body temperature. These effects appear to work through NMDA receptors in the suprachiasmatic nucleus, the brain’s master clock. When that brain region was surgically removed in animal studies, glycine’s sleep-promoting and temperature-lowering effects disappeared entirely.⁷

This creates something of a paradox for the headache question. Poor sleep is one of the most reliable migraine triggers, and interventions that improve sleep quality tend to reduce headache frequency over time. If glycine genuinely helps someone sleep better, the net effect on headache could be protective even if glycine also has theoretical headache-promoting properties through NMDA activation and vasodilation. The indirect benefit of better sleep might outweigh any direct risk from the receptor-level mechanisms. For the many people who take glycine specifically for sleep, this trade-off is probably favorable, though it has not been formally measured.

Collagen Supplements as a Stealth Glycine Source

Many people consume significant amounts of glycine without realizing it, particularly through collagen and gelatin supplements. Collagen is the most abundant protein in the human body, and roughly one in every three amino acid residues in its structure is glycine. A typical 10-gram serving of hydrolyzed collagen delivers about 2 to 3 grams of glycine, comparable to doses used in sleep research.

If glycine were a common headache trigger, you would expect to see headache reports surface frequently in collagen supplement trials. The meta-analysis of collagen peptide trials for osteoarthritis found that adverse event rates were statistically indistinguishable from placebo.¹¹ Bone broth, another popular source, delivers variable but often substantial amounts of glycine depending on preparation. The widespread consumption of these glycine-rich foods and supplements without a corresponding wave of headache complaints is itself informative, though it is epidemiological silence rather than positive evidence.

That said, someone who is already taking a standalone glycine supplement and then adds a collagen supplement and bone broth to their routine could be stacking glycine intake higher than they realize. If headaches happen to coincide with that combination, glycine would be worth examining as a variable to adjust.

Practical Guidance for People Who Are Wondering

If you have started taking glycine and noticed headaches, the most useful approach is also the simplest: stop for a week or two and see if the headaches resolve, then reintroduce at a lower dose. Genuine cause-and-effect is hard to establish with supplements because so many other variables change day to day, but a clear pattern of headaches appearing with glycine and disappearing without it is meaningful personal data even in the absence of clinical trial confirmation.

People with a history of migraine with aura have the strongest theoretical reason for caution, given the cortical spreading depression connection. This does not mean they should avoid glycine, but starting at a low dose and paying attention to any change in headache pattern is sensible. Anyone taking very high doses of glycine for a specific medical purpose, as in the schizophrenia research protocols, should be doing so under medical supervision regardless of headache concerns, because GI effects are well documented at those levels.

For the majority of people taking glycine at standard supplement doses of 3 to 5 grams, the available evidence suggests that headache is an uncommon reaction at most. The clinical trial record does not flag it as a notable risk, the biological mechanisms cut in both directions, and the blood-brain barrier limits how much oral glycine actually reaches the receptor systems in question. The honest summary is not that glycine cannot cause headaches, but that the evidence for it doing so is speculative rather than clinical, and the more extensively studied side effects are digestive rather than neurological.